Searched for
OTSUKA PHARMA
Japan's Topix posts record-high close despite US tariffs on pharmaJapan's broad Topix index closed at an all-time high on Friday, despite pressure from pharmaceutical shares following new tariffs on the se...- Japan's Topix hits record high despite US tariffs on pharmaJapan's Topix index reached a record high on Friday. This happened despite pharmaceutical shares facing pressure. The Nikkei index, however...
- Lupin launches generic version of kidney disorder treatment drug in USLupin Ltd has launched generic Tolvaptan tablets in the US, after receiving USFDA approval. These tablets, with strengths of 15 mg, 30 mg, ...
- Alembic Pharma gets USFDA nod to market generic antidepressant drugThe company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. ...
- New treatment to be made affordable for patients: TB AlliancePretomanid is the third TB drug to have been approved by the USFDA in the last 40 years.
- USFDA okays new antibiotic for highly drug-resistant tuberculosisPretomanid, a new chemical entity, was under development since 2002 by the TB Alliance.
- Hold Hexaware Technologies, target Rs 360: Edelweiss SecuritiesHexaware Technologies is a midcap company, operating in information technology sector.
- Carlyle in talks to invest $100 million in BDR PharmaBDR clocked Rs 550-600 crore in revenue and around Rs 120 crore in FY18 EBITDA.
- Health Ministry dragged to court over curbs on TB drugsThe drugs –– Bedaquiline by US drugmaker J&J and Delamanid by Japanese drugmaker Otsuka Pharma –– are the only treatment option for patient...
- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
- Aurobindo gains on USFDA final nod for anti-psychotic tabletsShares of Aurobindo Pharma climbed five per cent today as the company has received final approval from the US health regulator FDA to manuf...
- MNCs deprive India of vital drugs despite getting monopoly rightsJapanese firm Otsuka Pharmaceuticals, Myers-Squibb, Novartis are deferring launch of medicines critical for treatment of serious non-commun...
- Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...
- Govt approves 12 FDI proposals worth over Rs 2,609 crThe government today said it has approved 12 FDI proposals, including that of pharma firm Claris Otsuka, totalling over Rs 2,609 crore.
- FDC owners in talks to exit; plan to sell their 67% stakeBuyout fund Carlyle had shown interest in buying the company and had even valued it at about Rs 3,800 crore.
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Ranbaxy to shift admin to MumbaiRanbaxy Laboratories, India’s largest pharma company by sales, is looking to shift its marketing and administrative teams from its Gurgaon ...
- Wockhardt's product refused patentThe patent office in Mumbai has rejected Wockhardt’s application for a product patent for its product - nadifloxacin - a topical antibiotic...
Load More
